Navigation Links
Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain

ry endpoint of Peripheral Neuropathy Quality of Life Scale Composite score, the DMQ 45 patients showed a greater improvement than placebo patients (p=0.05) and the DMQ 30 patients showed a greater improvement than placebo patients (p=0.08).

Overall, the safety data from this study are consistent with data from previous studies. The most commonly reported adverse events were dizziness, nausea, diarrhea, fatigue and somnolence and were generally mild to moderate in nature. A higher number of patients in the DMQ 45 and DMQ 30 treatment groups (25.2% and 21.0%, respectively) discontinued due to an adverse event than compared to placebo (11.4%). There were no significant differences in serious adverse events with 7.6%, 4.8% and 4.1% reported in the DMQ 45, DMQ 30 and placebo groups, respectively. In addition, no deaths occurred throughout the study. Further safety and efficacy analyses are on-going and are expected to be presented at an upcoming public medical forum.

"We are extremely encouraged by the results of this trial which are consistent with Avanir's prior Phase II study in patients with diabetic neuropathic pain," said Randall Kaye, MD, Senior Vice President and Chief Medical Officer of Avanir Pharmaceuticals. "We look forward to meeting with the FDA to discuss the next study for Zenvia for the treatment of diabetic neuropathic pain given the robustness of the clinical results."

"Current treatment options are either partially effective or don't work at all for more than one-half of people suffering from diabetic neuropathic pain. The results of this study provide additional evidence that Zenvia, if approved, may be a safe and effective treatment option for the millions of Americans suffering from diabetic neuropathic pain," said Keith A. Katkin, President and CEO of Avanir Pharmaceuticals. "Avanir now has two Phase III Zenvia programs in areas with significant unmet medical need, one in Involuntary Emotional Expression Disorder (IEED) and on
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:1/23/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5dh22x/urinary_catheters ) has ... (Indwelling or Foley Catheters, Intermittent Catheters and Male External ... Growth, Trends and Forecast 2014 - 2020" report ... the global market for urinary catheters is experiencing a ...
(Date:1/23/2015)... 23, 2015 More than a third of reproductive-aged women ... with private insurance, filled a prescription for an opioid pain ... this week,s Morbidity and Mortality Weekly Report (MMWR). ... treat moderate to severe pain.  They are also found in ...
(Date:1/23/2015)... 2015  Now available for sale, The Armor1 Ankle Roll ... ankle sprains by cushioning the ankle from an inversion ... the outside of any shoe type and allows the ... offering protection against sprains. With customers in physical therapy, ...
Breaking Medicine Technology:Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... announces that a new market research report is ... Markets for Video, High-Tech and Integrated OT Equipment ... The European Markets for Video, High-Tech ... Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain ...
... 14, 2010 Verenium Corporation (Nasdaq: VRNM ... high-performance industrial enzyme solutions, today announced key ... "2010 has been a significant year of ... oriented to being focused on building the next leading ...
Cached Medicine Technology:Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 2Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 3Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 4Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 5Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 6Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 7Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 8Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 9Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 10Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 11Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 12Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 13Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 14Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 15Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 16Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 17Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 18Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 19Verenium Announces 2010 Business Update and Outlook for 2011 2Verenium Announces 2010 Business Update and Outlook for 2011 3Verenium Announces 2010 Business Update and Outlook for 2011 4Verenium Announces 2010 Business Update and Outlook for 2011 5
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased ... Clinical Pharmacy Services at North Carolina State’s College of ... 2015 Beal Award for Distinguished Volunteer Service—the organization’s highest ... the contributions of volunteer experts to direct its work ...
(Date:1/22/2015)... Hollywood, California (PRWEB) January 22, 2015 The City ... 2015 at 10 a.m., to commemorate the 42nd anniversary of the ... United States. , “It’s been 42 years since the Roe vs. ... choose is still as present as ever,” said City of West ...
(Date:1/22/2015)... January 22, 2015 Padre Murphy's and Owner ... of Pro Player Health Alliance (PPHA). The PPHA's ... in getting everyone, including NFL greats, treated for obstructive sleep ... leading groups supporting the cause in the valley. The most ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company ... to follow it on Facebook, Twitter, and Pinterest. The fans ... Angelweddingdress draws a lottery every week. , Moreover, the company ... 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
... HOUSTON - A gene therapy invented at The University of ... succeed in a U.S. phase III clinical trial for cancer, ... annual meeting in Boston. , Introgen Therapeutics, Inc., reported ... adenovirus that expresses the tumor-suppressing gene p53, for end-stage head ...
... performance effort encourages optimal care,of patients with depression, ... for U.S. employers estimated at more than $44 billion ... care for patients with,depression, the Buyers Health Care Action ... program with a pilot in Minnesota. BTE is the,nation,s ...
... (OTC Bulletin Board: VHGI) has named Robert Tapales ... Robert,previously served as COO and EVP of VPS ... VHGI as part of its acquisition of VPS ... years experience in the healthcare industry, ranging,from clinical ...
... you taking or did you take hormones? If yes, which ... taking hormone replacement medication? 3,464 breast cancer patients and 6,657 ... participated in a large survey and elicited detailed information about ... for relief of menopausal symptoms. The survey was prompted by ...
... in German . , A measuring ... to investigate in some detail the behaviour of magnetic ... nanoparticles (with a size of some few to several ... cancer. The particles serve as a carrier for drugs: ...
... of iron and offers a good set of proteins. ... Charlotte Eklund-Jonsson at the Department of Food Science, Chalmers University ... moreover a whole-grain product with high folate content. It ... of cardiovascular diseases, and it is also believed that it ...
Cached Medicine News:Health News:Gene therapy increases survival for end-stage head and neck cancer 2Health News:Gene therapy increases survival for end-stage head and neck cancer 3Health News:Gene therapy increases survival for end-stage head and neck cancer 4Health News:Buyers Health Care Action Group Pilots New Bridges to Excellence Program for Depression 2Health News:Buyers Health Care Action Group Pilots New Bridges to Excellence Program for Depression 3Health News:VirtualHealth Technologies, Inc. Announces Management Appointment 2Health News:Long-term hormone replacement therapy increases breast cancer risk 2Health News:Magnetic nanoparticles: Suitable for cancer therapy? 2
Lacrimal Cannula, Curved - Closed End, CurvedSize: 25g x 1-1/2"....
PremierEdge™ Slit Knives....
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Medicine Products: